{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "e8b9035f",
   "metadata": {},
   "source": [
    "# Batch Legal Preproc Mockup Model V2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d4e164f",
   "metadata": {},
   "source": [
    "Adjusted preprocessing steps: No sentence tokenization in this version."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "d5e5bdcf",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Imports\n",
    "\n",
    "import pandas as pd\n",
    "import string\n",
    "from bs4 import BeautifulSoup\n",
    "from nltk.tokenize import word_tokenize, sent_tokenize\n",
    "from nltk.corpus import stopwords \n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from nltk.collocations import *\n",
    "\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "from sklearn.decomposition import LatentDirichletAllocation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "0452bb33",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Loading data from csv\n",
    "data = pd.read_csv(\"../raw_data/test_data_scraped.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "7abf8765",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "str"
      ]
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Tokenizing the sentences\n",
    "\n",
    "test_data = data['content'][0]\n",
    "type(test_data)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "578be72d",
   "metadata": {},
   "source": [
    "Ignore list should be updated after once running the preproc on the entire dataset "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "a56f89aa",
   "metadata": {},
   "outputs": [],
   "source": [
    "# list used to remove unrelevant terms \n",
    "ignore_list = {'ec', 'no', 'european', 'commission', 'eu', 'union',\n",
    "                   'article', 'directive', 'council', 'regulation', 'official',\n",
    "                   'journal', 'article', 'information', 'agency', 'regulation',\n",
    "                   'mssg', 'data', 'member', 'states', 'etf', 'mdssg', 'shall'\n",
    "                  }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "b80f77c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Defining Davy's Preproc-Function\n",
    "\n",
    "def cleaning(sentence):\n",
    "    \n",
    "    # Basic cleaning\n",
    "    sentence = sentence.strip() ## remove whitespaces\n",
    "    sentence = sentence.lower() ## lowercasing \n",
    "    sentence = ''.join(char for char in sentence if not char.isdigit()) ## removing numbers\n",
    "    \n",
    "    # Advanced cleaning\n",
    "    for punctuation in string.punctuation:\n",
    "        sentence = sentence.replace(punctuation, '') ## removing punctuation\n",
    "    tokenized_sentence = word_tokenize(sentence) ## tokenizing \n",
    "    stop_words = set(stopwords.words('english')) ## defining stopwords\n",
    "    tokenized_sentence_cleaned = [w for w in tokenized_sentence \n",
    "                                  if not w in stop_words] ## remove stopwords\n",
    "    tokenized_sentence_cleaned = [w for w in tokenized_sentence_cleaned\n",
    "                                  if not w in ignore_list]\n",
    "    lemmatized = [WordNetLemmatizer().lemmatize(word, pos = \"v\")  # v --> verbs\n",
    "              for word in tokenized_sentence_cleaned]\n",
    "    lemmatized = [WordNetLemmatizer().lemmatize(word, pos = \"n\")  # n --> nouns\n",
    "              for word in tokenized_sentence_cleaned]\n",
    "    lemmatized = [WordNetLemmatizer().lemmatize(word, pos = \"a\") # Lemmatizing the adjectives\n",
    "              for word in tokenized_sentence_cleaned]\n",
    "    lemmatized = [WordNetLemmatizer().lemmatize(word, pos = \"r\") # Lemmatizing the adverbs\n",
    "              for word in tokenized_sentence_cleaned]\n",
    "    cleaned_sentence = ' '.join(word for word in lemmatized)\n",
    "    return cleaned_sentence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "ecfe7b7d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Applying Davy's Function\n",
    "\n",
    "clean_txt = cleaning(test_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "abc7b1fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'parliament regard treaty functioning particular point c thereof regard proposal transmission draft legislative act national parliaments regard opinion economic social committee regard opinion committee regions acting accordance ordinary legislative procedure whereas pursuant articles treaty functioning ‘ tfeu ’ charter fundamental rights ‘ charter ’ ensure high level human health protection definition implementation policies activities covid pandemic highlighted interconnectedness human animal ecosystem health risks posed loss biodiversity earth recognised world health organization many microbes infect animals humans efforts focus human health animal health prevent eliminate problem disease transmission diseases may transmitted humans animals vice versa therefore need tackled humans animals taking advantage potential synergies research treatments approximately emerging diseases almost known pandemics namely influenza hivaids covid zoonoses diseases increased globally past years changes land use deforestation urbanisation agricultural expansion intensification wildlife trafficking consumption patterns factors contributed increase zoonotic pathogens bacterial viral parasitic include unconventional agents able spread humans direct contact food water environment covid pandemic clear example need reinforce application one health approach achieve well public health outcomes since stated parliament ‘ human health connected animal health environment … actions tackle threats health must take account three dimensions ’ unprecedented experience covid pandemic also highlighted difficulties addressing public health emergency regard demonstrated need strengthen ’ role order effective managing availability medicinal products availability medical devices vitro diagnostic medical devices respective accessories collectively ‘ medical devices ’ developing medical countermeasures address threats posed public health early stage harmonised way ensures cooperation coordination national regional competent authorities medicinal products medical devices industry actors supply chains medicinal products medical devices including healthcare professionals needs give higher priority health ability ensure continued provision high quality healthcare services prepared address pandemics health threats severely impeded absence clearly defined legal framework managing response pandemics limited mandates resources health agencies well limited degree preparedness public health emergencies impact majority shortages medicinal products medical devices different complex root causes need mapped understood analysed together different stakeholders order comprehensively addressed well understanding shortages include identification vulnerabilities supply chain specific case covid pandemic shortage treatments disease variety causes ranging production difficulties third countries logistical production difficulties within shortage vaccines due inadequate manufacturing capacity disruptions often complex supply chains medicinal products medical devices national export restrictions bans border closures impeding free movement goods uncertainty related supply demand goods context covid pandemic lack production certain medicinal products active substances led significant impediments smooth functioning internal market addressing serious threats public health across serious consequences ’ citizens addressing issue shortages medicinal products longstanding priority parliament illustrated several reports parliament parliament resolution september shortage medicines – address emerging problem well discussions within however issue remained date unaddressed shortages medicinal products represent growing threat public health serious impact healthcare systems right patients access appropriate medical treatment increased global demand medicinal products exacerbated covid pandemic led shortages medicinal products weakening healthcare systems posing significant risks patients ’ health care patients particularly terms disease progression worsening symptoms longer delays interruptions care therapy longer periods hospitalisation increased risk exposure falsified medicinal products medication errors adverse effects resulting substitution unavailable medicinal products alternative ones significant psychological distress patients increased costs healthcare systems covid pandemic exacerbated problem shortages certain medicinal products considered critical addressing pandemic highlighted ’ external dependence terms domestic production medicinal products medical devices lack coordination structural limitations ’ ’ ability rapidly effectively react challenges public health emergencies also highlighted need support strengthen industrial capacities produce medicinal products medical devices appropriate policies well need active extensive involvement institutions bodies offices agencies protecting health citizens rapid evolution covid spread virus led sharp increase demand medical devices ventilators surgical masks covid test kits disruption production limited capacity rapidly increase production complexity global nature supply chain medical devices led severe supply difficulties certain times serious shortages medical devices also led competing respond legitimate needs citizens thereby contributing uncoordinated actions national level national hoarding stockpiling issues resulted new entities involved expedited production medical devices subsequently resulted delays conformity assessments prevalence medical devices overpriced noncompliant unsafe cases counterfeits therefore appropriate matter urgency longterm structures established within medicines ‘ ’ established parliament ensure solid effective monitoring shortages medical devices occur public health emergency coordination management shortages well increased early dialogue medical devices industry healthcare professionals prevent mitigate shortages covid pandemic subsequent public health emergency revealed need coordinated approach crisis management although lack impact assessment accompanying proposal due emergencylike nature situation sufficient allocation resources terms staff funding secured taking account specificities health sector different uncertainty supply demand risk shortages medicinal products medical devices public health emergency like covid pandemic trigger export restrictions among national protective measures seriously impact functioning internal market thereby exacerbating consequences public health well leading need temporary export transparency export authorisation mechanisms furthermore shortages medicinal products result serious risks health patients due lack availability result medication errors increased duration hospital stays adverse reactions increased risk fatalities caused administration unsuitable medicinal products used substitute unavailable medicinal products respect medical devices shortages lead lack diagnostic resources negative consequences public health measures disease deteriorating treated may also prevent health professionals adequately carrying tasks protected evidenced covid pandemic serious consequences health shortages example insufficient supply covid test kits also significant impact control spread given pathogen therefore important appropriate framework level coordinate response shortages medicinal products medical devices reinforce formalise monitoring critical medicinal products medical devices efficient way way avoids creating unnecessary burdens stakeholders place strain resources cause additional delays safe efficacious medicinal products treat prevent diagnose diseases cause public health emergencies identified developed notably joint efforts public authorities private sector academia made available citizens soon possible emergencies covid pandemic also highlighted need coordinate assessments conclusions multinational clinical trials line done voluntary basis clinical trials experts prior date application parliament need unionlevel advice use medicinal products national compassionate use programmes use medicinal products indications covered marketing authorisation order avoid delays implementation results research development availability new repurposed medicinal products covid pandemic ad hoc solutions contingent arrangements marketing authorisation holders manufacturers actors supply chain medicinal products one side found order make available safe efficacious medicinal products treat covid prevent spread order facilitate speed development marketing authorisation treatments vaccines order ensure well functioning internal market safe efficacious medicinal products treatment covid prevention spread contribute high level human health protection therefore appropriate approximate strengthen rules monitoring shortages medicinal products medical devices facilitate research development medicinal products potential treat prevent diagnose diseases cause public health emergencies view strategically complementing efforts including health emergency preparedness response authority ‘ hera ’ established decision september agencies end order support assessment crisispreparedness crisismanagement framework provided regard shortages medicinal products medical devices able use outcomes targeted stress tests performed relevant actors stress tests entail simulation public health emergency major event segments processes procedures laid tested aims ensure high level protection human health ensuring smooth functioning internal market regards medicinal products medical devices moreover aims ensure quality safety efficacy medicinal products potential address public health emergencies objectives pursued simultaneously inseparably linked without one secondary regards tfeu establishes framework monitoring reporting shortages medicinal products medical devices public health emergencies major events regards point c tfeu provide strengthened framework ensuring quality safety medicinal products medical devices establish framework address issue shortages medicinal products medical devices public health emergencies major events however shortages persistent problem increasingly affecting health lives citizens decades therefore first step towards improving response persistent problem subsequently assess expansion framework ensure issue shortages medicinal products medical devices addressed order improve crisis preparedness management respect medicinal products medical devices increase resilience solidarity across procedures respective roles obligations different entities concerned clarified framework established build ad hoc solutions identified date response covid pandemic proven effective build experience best practices examples third countries remaining flexible enough tackle future public health emergency major event efficient way benefit public health patients harmonised system monitoring shortages medicinal products medical devices established would facilitate appropriate access critical medicinal products medical devices public health emergencies major events serious impact public health system complemented improved structures ensuring appropriate management public health emergencies major events coordinating providing advice research development relating medicinal products potential mitigate public health emergencies major events order facilitate monitoring reporting actual potential shortages medicinal products medical devices able request obtain marketing authorisation holders concerned manufacturers designated single points contact avoiding duplication requested submitted interfere obligation marketing authorisation holders parliament notify state product ceases placed market state obligation marketing authorisation holders wholesale distributors ensure appropriate continued supplies medicinal product persons legal entities authorised entitled supply medicinal products needs patients state question met order facilitate prevention monitoring reporting shortages medicinal products set technology platform known shortages monitoring platform ‘ esmp ’ capable processing supply demand critical medicinal products public health emergencies major events outside situations allow reporting shortages medicinal products likely lead public health emergencies major events facilitate development esmp existing systems leveraged used possible esmp allow national competent authorities submit monitor unmet demand including received marketing authorisation holders wholesale distributors persons legal entities authorised entitled supply medicinal products public order anticipate shortages medicinal products esmp could also process additional received marketing authorisation holders wholesale distributors persons legal entities authorised entitled supply medicinal products public order avert public health emergency major event esmp fully implemented act sole portal marketing authorisation holders provide required public health emergencies major events view increasing efficiency predictability public health emergencies major events accelerating decisionmaking process avoiding duplication efforts unjustified burdens stakeholders order facilitate coordination role interoperability existing ’ platforms monitoring shortages systems appropriate essential allow sharing relevant esmp managed event actual future demand unknown due public health emergency major event important make pragmatic predictions demand certain medicinal products basis best available context available stocks planned minimum stocks collected taken account identifying demand far possible essential making correct adjustments manufacturing medicinal products avoid least mitigate impact shortages medicinal products however stocks available provided due national security interests provide estimated volumes demand respect medicinal products executive steering group established within ensure robust response major events coordinate urgent actions within relation management issues relating supply medicinal products ‘ medicine shortages steering group – ’ establish lists critical medicinal products ensure monitoring products able provide advice recommendations necessary action take safeguard quality safety efficacy medicinal products well safeguard supply medicinal products ensure high level human health protection facilitate appropriate communication patients consumers one hand could collect impact shortages medicinal products patients consumers share relevant order inform approaches management shortages medicinal products order ensure inclusivity transparency work appropriate engagement relevant third parties including representatives medicinal product interest groups marketing authorisation holders wholesale distributors appropriate actors supply chain medicinal products representatives healthcare professionals patients consumers benefit ’ extensive scientific expertise regards evaluation supervision medicinal products develop ’ leading role coordinating supporting response shortages medicinal products covid pandemic order ensure high quality safe efficacious medicinal products potential address public health emergencies developed made available within soon possible public health emergencies emergency task force established within provide advice medicinal products ‘ emergency task force – ’ provide advice scientific questions related development treatments vaccines clinical trial protocols free charge entities involved development marketing authorisation holders clinical trial sponsors public health bodies academia irrespective role development medicinal products decisions clinical trial applications remain within competence accordance work separate work scientific committees carried without prejudice scientific assessments committees provide advice recommendations regard use medicinal products fight overcome publichealth emergencies committee medicinal products human use ‘ chmp ’ established able use recommendations preparing scientific opinions compassionate early use medicinal product prior marketing authorisation could also draw work developing critical medicines lists establishment etfshould build support provided covid pandemic particular regards scientific advice clinical trials design product development well ‘ rolling ’ review emerging evidence ie ongoing basis allow efficient assessment medicinal products including vaccines public health emergencies guaranteeing high level human health protection order ensure well functioning internal market medicinal products contribute high level humanhealth protection appropriate coordinate provide advice developers involved research development medicinal products potential treat prevent diagnose diseases causing public health emergency provide advice clinical trial protocols developers clinical trials conducted providing guidance clinically relevant endpoints targets vaccines treatments order facilitate clinical trial design meeting criteria effective public health interventions experience clinical trials covid pandemic revealed tremendous amount duplication investigations interventions high number small trials underrepresentation important population subgroups based gender age ethnicity medical comorbidities lack collaboration leading risk research wasted international regulators pointed need improve clinical research agenda order generate robust evidence quality safety efficacy medicinal products main way obtaining reliable evidence coordinated welldesigned adequately powered large randomised controlled trials clinical trial results clinical produced relevant marketing authorisation granted made publicly available timely manner publication trial protocol start clinical trial would allow public scrutiny whenever necessary considering medicinal products human use may impact veterinary sector close liaison national competent authorities veterinary medicinal products envisaged although individual research entities may agree another party act sponsor order prepare single harmonised unionwide clinical trial protocol experience covid pandemic shown initiatives set large multinational trials struggle materialise due lack single entity able take responsibilities activities sponsor within well interact multiple address problem new unionwide unionfunded vaccine trial network called vaccelerate launched following communication february entitled ‘ hera incubator anticipating together threat covid variants ’ identify facilitate initiatives giving advice possibilities acting sponsor applicable allocating respective responsibilities cosponsors accordance coordinate development clinical trial protocols approach would strengthen research environment would promote harmonisation would avoid subsequent delays availability results research marketing authorisation files sponsor could benefit research funding available time public health emergency well existing clinical trial networks facilitate development application submission running trials may particularly valuable trials established international public health research organisations publishes public assessment reports epars medicinal products authorised accordance provide assessment medicinal products describing assessed reasons recommending whether medicinal product authorised epar includes detailed regard relevant presubmission activities including names coordinators experts involved medicinal product developer requests scientific advice presubmission phase overview scientific topics discussed view advice respect medical devices executive steering group shortages medical devices established coordinate urgent actions within relation management supply demand issues medical devices establish list critical medical devices case public health emergency ‘ medical device shortages steering group – ’ ensure coordination also liaise medical devices coordination group ‘ mdcg ’ established parliament appropriate respect able appoint representatives mdcg operational phase work triggered recognition public health emergency accordance decision parliament regards also recognition major event continuous monitoring risks public health major events including manufacturing issues natural disasters bioterrorism potential affect quality safety efficacy supply medicinal products also ensured addition monitoring follow one health approach understood recommendations advice guidance opinions provided inherently nonbinding instruments intended allow make views known suggest line action without imposing legal obligation addressees instruments imperative place robust transparency measures standards regarding ’ regulatory activities relation medicinal products medical devices fall scope measures include timely publication relevant approved medicinal products medical devices clinical including clinical trial protocols highly transparent regards membership recommendations opinions decisions members financial interests medicinal products medical device industries could affect impartiality order establish list categories critical medical devices facilitate process monitoring shortages manufacturers medical devices authorised representatives necessary relevant notified bodies provide requested specific situations namely state considers need provide temporary exemptions pursuant parliament view mitigating actual potential shortages medical devices importer distributor also play role providing requested noneu manufacturer designated authorised representative provide role supporting expert panels medical devices designated accordance ‘ expert panels ’ providing independent scientific technical assistance mdcg notified bodies manufacturers upholding maximum transparency condition fostering trust confidence regulatory system addition role clinical evaluation assessments performance evaluations regarding certain high risk medical devices accordance regulations respectively well providing opinions response consultation manufacturers notified bodies expert panels provide scientific technical clinical assistance mdcg particular expert panels contribute development guidance number points including clinical performance aspects specific medical devices categories groups medical devices specific hazards related category group medical devices develop clinical evaluation performance evaluation guidance line state art contribute identification concerns emerging issues safety performance context expert panels could play relevant role preparedness management public health emergencies relating medical devices particularly high risk including medical devices potential address public health emergencies without prejudice tasks obligations regulations given ’ longstanding proven record expertise field medicinal products considering ’ experience working multitude groups experts appropriate establish suitable structures within monitor potential shortages medical devices context public health emergency provide provide secretariat expert panels would ensure expert panels operate sustainably long term would provide clear synergies related crisispreparedness work area medicinal products structures would way change regulatory system decisionmaking procedures area medical devices already place remain clearly distinct medicinal products ensure smooth transition provide support expert panels march order facilitate work exchanges provision made establishment management infrastructures create synergies existing systems systems development including database medical devices eudamed provided alongside enhanced protection infrastructure deterrence possible cyber attacks within eudamed medical device nomenclature provided used help gathering relevant categorisation medical devices work could also facilitated appropriate emerging digital technologies computational models simulations clinical trials well space programme established parliament galileo geolocation services copernicus earth observation order ensure completeness obtained considering specific characteristics medical device sector eudamed fully functional possible constitute list single points contact monitoring shortages medical devices included public health emergency critical devices list using source relevant databases medical device associations national level rapid access exchanges health including real world ie health generated outside clinical studies essential ensuring effective management public health emergencies major events allow use facilitate exchanges part establishment operation health space interoperable infrastructure taking advantage potential supercomputing artificial intelligence big science develop predicting models take well timely effective decisions without compromising privacy rights order facilitate reliable exchange medicinal products robust consistent manner identification medicinal products based standards developed international organization standardization identification medicinal products human use handling sensitive crucial dealing potential public health emergencies requires high level protection cyber attacks healthcare organisations also facing heightened cybersecurity threats midst covid pandemic target cyber attack resulted documents related covid medicinal products vaccines belonging third parties illegally accessed documents leaked internet therefore necessary equipped high level security controls processes cyber attacks ensure operates normally times especially public health emergencies major events end establish plan prevent detect mitigate respond cyber attacks operations secure times preventing illegal access documentation held due sensitive nature health safeguard processing operations ensure respect protection principles lawfulness fairness transparency purpose limitation minimisation accuracy storage limitation integrity confidentiality processing personal necessary purposes processing done accordance law protection personal processing personal take place accordance regulations parliament credibility public trust decisions depend high degree transparency therefore use adequate communication tools proactively engage general public provided addition rapid strengthening transparency standards measures regarding ’ working bodies clinical assessed evaluation surveillance medicinal products medical devices paramount gain uphold public trust establish framework strengthened transparency standards measures basis transparency standards measures adopted covid pandemic public health emergencies major events ensure cooperation centre disease prevention control ‘ ecdc ’ established parliament agencies appropriate cooperation include sharing including epidemiological forecasting regular communication executive level inviting representatives ecdc agencies attend meetings appropriate cooperation also include strategic discussions relevant entities position assist research development regarding appropriate solutions technologies mitigating effects public health emergency major event preventing future similar public health emergencies major events cases public health emergencies relation major events possible enable regular exchanges marketing authorisation holders relevant actors supply chain medicinal products representatives healthcare professionals patients consumers ensure early discussions potential shortages medicinal products market supply constraints allow well coordination synergies mitigate respond public health emergency major event given covid pandemic come end duration evolution public health emergencies pandemics uncertain provision made review effectiveness functioning structures mechanisms established accordance light review structures mechanisms adjusted appropriate since objectives sufficiently achieved alone due crossborder dimension public health emergencies major events rather reason scale effects action well achieved level may adopt measures accordance principle subsidiarity set treaty accordance principle proportionality set go beyond necessary order achieve objectives order ensure sufficient resources including appropriate staffing adequate expertise available carrying tasks provided expenditure covered contribution ’ revenue expenditure include remuneration rapporteurs appointed provide scientific services relation line usual practice reimbursement travel accommodation subsistence expenses related meetings working parties euhealth programme established recovery resilience facility established parliament tools provide additional support national competent authorities relation shortages medicinal products including implementation actions mitigate shortages medicinal products improve security supply able request financial support specifically implementation obligations set protection supervisor consulted accordance delivered formal comments march accordance tfeu fully respects responsibilities definition health policy organisation delivery health services medical care well fundamental rights principles recognised charter including protection personal one aims ensure strengthened framework monitoring reporting shortages medicinal products public health emergencies major events announced communication november entitled ‘ pharmaceutical strategy europe ’ propose revise pharmaceutical legislation enhance security supply address shortages medicinal products specific measures legislation could cover coordinating role monitoring managing shortages medicinal products result revision strengthened measures regarding monitoring reporting supply demand medicinal products level required esmp considered suitable system facilitate new provisions relating monitoring reporting shortages medicinal products part reporting consider need extend scope include veterinary medicinal products personal protective equipment amend definitions introduce measures national level strengthen compliance obligations set review include consideration remit functioning esmp extension functioning esmp need national shortages monitoring systems considered necessary order prepare shortages medicinal products public health emergencies major events support monitoring shortages capacity building supported funding mechanisms considered order enhance cooperation among could include exploration best practices coordination development tools monitoring managing shortages medicinal products connecting esmp ensure esmp used full potential identify forecast problems relating supply demand medicinal products appropriate esmp facilitate use big techniques artificial intelligence order allow prompt application measures provided enter force day following publication adopted within medicines ‘ ’ provides framework means preparing preventing coordinating managing impact public health emergencies medicinal products medical devices impact major events medicinal products medical devices level b monitoring preventing reporting shortages medicinal products shortages medical devices c setting interoperable technology platform level monitor report shortages medicinal products providing advice medicinal products potential address public health emergencies e providing support expert panels provided purposes following definitions apply ‘ public health emergency ’ means situation public health emergency recognised accordance decision b ‘ major event ’ means event likely pose serious risk public health relation medicinal products one state concerns deadly threat otherwise serious threat health biological chemical environmental origin serious incident affect supply demand medicinal products quality safety efficacy medicinal products may lead shortages medicinal products one state necessitates urgent coordination level order ensure high level human health protection c ‘ medicinal product ’ means medicinal product defined point ‘ veterinary medicinal product ’ means veterinary medicinal product defined point parliament e ‘ medical device ’ means medical device defined point vitro diagnostic medical device defined point includes accessories devices within meaning point point respectively f ‘ supply ’ means total volume stock given medicinal product medical device placed market marketing authorisation holder manufacturer g ‘ demand ’ means request medicinal product medical device healthcare professional patient response clinical need demand satisfactorily met medicinal product medical device acquired appropriate time sufficient quantity allow continuity best care patients h ‘ shortage ’ means situation supply medicinal product authorised placed market state cemarked medical device meet demand medicinal product medical device national level whatever cause ‘ developer ’ means legal natural person seeking generate scientific regard quality safety efficacy medicinal product part development product executive steering group shortages safety medicinal products ‘ medicine shortages steering group – ’ hereby established within responsible fulfilling tasks referred articles meet regularly also whenever situation requires either person remotely preparation public health emergency issue concern raised recognised major event accordance provide secretariat members consist representative representative one representative appointed state members may accompanied meetings experts specific scientific technical fields list members published ’ web portal representative ’ patients ’ consumers ’ working party ‘ pcwp ’ representative ’ healthcare professionals ’ working party ‘ hcpwp ’ may attend meetings observers cochaired representative one representatives elected among representatives cochairs initiative request one members may invite observers provide expert advice representatives national competent authorities veterinary medicinal products representatives relevant competent authorities third parties including representatives medicinal product interest groups marketing authorisation holders wholesale distributors appropriate actor supply chain medicinal products representatives healthcare professionals patients consumers attend meetings necessary coordination national competent authorities medicinal products facilitate appropriate communication marketing authorisation holders representatives manufacturers relevant actors supply chain medicinal products representatives healthcare professionals patients consumers view receiving relevant actual potential shortages medicinal products considered critical public health emergency major event provided establish rules procedure including procedures relating working party referred paragraph procedures adoption critical medicines lists sets recommendations referred rules procedure referred first subparagraph enter force received favourable opinion management board supported work working party established accordance point working party referred first subparagraph consist representatives national competent authorities medicinal products single points contact relation shortages medicinal products may consult committee medicinal products veterinary use ‘ cvmp ’ established point b whenever deems necessary particular order deal public health emergencies major events related zoonoses diseases affect animals may major impact human health use active substances veterinary medicinal products may useful addressing public health emergency major event collaboration continuously monitor event likely lead public health emergency major event necessary cooperate centre disease prevention control ‘ ecdc ’ relevant agencies facilitate monitoring referred paragraph national competent authorities medicinal products acting single points contact referred platform referred ‘ esmp ’ fully functional report timely manner event likely lead public health emergency major event including actual potential shortage medicinal product given state reporting based reporting methods criteria pursuant point b national competent authority informs shortage medicinal product referred first subparagraph provide received marketing authorisation holder pursuant available esmp receives report event national competent authority medicinal products may request national competent authorities working party referred order evaluate impact event considers actual imminent major event needs addressed raise issue concern following positive opinion may recognise major event least one state may raise issue concern initiative inform executive director considers major event sufficiently addressed considers assistance longer needed basis referred first subparagraph initiative executive director may confirm major event sufficiently addressed therefore assistance longer needed following recognition public health emergency recognition major event accordance paragraph articles apply follows public health emergency major event may affect quality safety efficacy medicinal products applies b public health emergency major event may lead shortages medicinal products one state articles apply following recognition public health emergency recognition major event accordance evaluate related public health emergency major event consider need urgent coordinated action regard quality safety efficacy medicinal products concerned provide recommendations appropriate action believes needs taken level medicinal products concerned accordance may consult cvmp whenever deems necessary particular order deal public health emergencies major events related zoonoses diseases affect animals may major impact human health use active substances veterinary medicinal products may useful addressing public health emergency major event without prejudice paragraph establish list main therapeutic groups medicinal products necessary emergency care surgery intensive care order inform preparation critical medicines lists referred paragraphs used respond public health emergency major event list established august updated annually whenever necessary immediately following recognition major event accordance consult working party referred immediately following consultation adopt list medicinal products authorised accordance considers critical major event ‘ major event critical medicines list ’ update major event critical medicines list whenever necessary major event sufficiently addressed confirmed assistance longer needed pursuant immediately following recognition public health emergency consult working party referred immediately following consultation adopt list medicinal products authorised accordance considers critical public health emergency ‘ public health emergency critical medicines list ’ update public health emergency critical medicines list whenever necessary termination recognition public health emergency public health emergency critical medicines list may updated take account results review process appropriate cases liaise emergency task force referred ‘ ’ purposes adopt make publicly available set referred points c necessary monitor supply demand medicinal products included lists referred paragraphs ‘ critical medicines lists ’ inform working party referred set following adoption critical medicines lists accordance paragraphs immediately publish lists updates lists web portal referred establish within web portal publicly accessible webpage provides actual shortages medicinal products included critical medicines lists cases assessed shortage provided recommendations healthcare professionals patients webpage provide least following name common name medicinal product critical medicines lists b therapeutic indications medicinal product critical medicines lists c reason shortage medicinal product critical medicines lists start end dates shortage medicinal product critical medicines lists e affected shortage medicinal product critical medicines lists f relevant healthcare professionals patients including whether alternative medicinal products available webpage referred first subparagraph also provide references national registries shortages medicinal products following recognition public health emergency recognition major event accordance monitor supply demand medicinal products included critical medicines lists view identifying actual potential shortages medicinal products conduct monitoring using critical medicines lists provided accordance articles available esmp fully functional purposes monitoring referred first paragraph relevant liaise health security committee established decision ‘ hsc ’ case public health emergency relevant advisory committee public health emergencies established pursuant law ecdc duration public health emergency following recognition major event referred confirmed major event sufficiently addressed pursuant regularly report results monitoring referred single points contact referred particular signal actual potential shortages medicinal products included critical medicines lists event likely lead major event reports referred first subparagraph may also made available actors supply chain medicinal products appropriate accordance competition law requested one single point contact referred provide aggregated demand forecasts support findings conclusions regard use esmp fully functional b liaise ecdc obtain epidemiological models development scenarios help forecast medicinal product needs c liaise executive steering group shortages medical devices referred ‘ ’ medicinal products included critical medicines lists used jointly medical device aggregated demand forecasts referred first subparagraph may also made available actors supply chain medicinal products appropriate accordance competition law view well preventing mitigating actual potential shortages medicinal products part reporting referred paragraphs may provide recommendations measures marketing authorisation holders entities including representatives healthcare professionals patients could take prevent mitigate actual potential shortages medicinal products may request provide recommendations measures referred first subparagraph purposes second subparagraph liaise relevant hsc case public health emergency relevant advisory committee public health emergencies established pursuant law initiative request state may provide recommendations measures marketing authorisation holders representatives healthcare professionals entities could take ensure preparedness dealing actual potential shortages medicinal products caused public health emergencies major events requested may coordinate measures taken national competent authorities marketing authorisation holders entities including representatives healthcare professionals patients relevant prevent mitigate actual potential shortages medicinal products context public health emergency major event order prepare fulfilment tasks referred articles specify procedures criteria establishing reviewing critical medicines lists b specify methods criteria monitoring collection reporting provided articles basic minimum set c develop streamlined monitoring reporting systems coordination relevant national competent authorities facilitate interoperability existing systems systems development esmp fully functional basis fields harmonised across establish working party referred ensure state represented working party e establish maintain list single points contact marketing authorisation holders medicinal products authorised database provided point l f specify methods provision recommendations referred coordination measures referred g publish covered points b f dedicated webpage web portal purposes first subparagraph point marketing authorisation holders relevant actors supply chain medicinal products representatives healthcare professionals patients consumers may consulted necessary following recognition public health emergency recognition major event accordance establish list single points contact marketing authorisation holders medicinal products included critical medicines lists b maintain list single points contact referred point duration public health emergency major event c request relevant medicinal products critical medicines lists single points contact referred point set deadline submission available esmp request medicinal products critical medicines lists single points contact referred basis set referred set deadline submission available esmp referred paragraph point c include least name marketing authorisation holder medicinal product b name medicinal product c identification active manufacturing sites finished products active substances medicinal product state marketing authorisation valid marketing status medicinal product state e details actual potential shortage medicinal product actual estimated start end dates suspected known cause f sales market share medicinal product g available stocks medicinal product h forecast supply medicinal product including potential vulnerabilities supply chain quantities already delivered projected deliveries demand forecasts medicinal product j details available alternative medicinal products k shortage prevention mitigation plans include minimum production supply capacity approved production sites finished medicinal product active substances potential alternative production sites minimum stock levels medicinal product order supplement shortage prevention mitigation plans critical medicinal products referred paragraph point k national competent authorities medicinal products may request wholesale distributors relevant actors regarding logistical challenges incurred wholesale supply chain marketing authorisation holders medicinal products authorised provide purposes point e september form electronic submission database referred point l marketing authorisation holders provide updates necessary order facilitate monitoring referred may request marketing authorisation holders medicinal products included critical medicines lists submit referred point c marketing authorisation holders referred first subparagraph paragraph submit requested deadline set single points contact referred point b using monitoring reporting methods systems established pursuant points b c respectively marketing authorisation holders provide updates necessary marketing authorisation holders referred paragraphs justify failure provide requested delays providing requested deadline set marketing authorisation holders referred paragraph indicate submitted request national competent authorities medicinal products contains commercially confidential nature identify relevant parts nature explain commercially confidential nature assess merits indication commercially confidential nature protect commercially confidential unjustified disclosure marketing authorisation holders referred paragraph relevant actors supply chain medicinal products addition required paragraph second subparagraph provides evidence actual potential shortage medicinal products immediately provide following reporting results monitoring referred recommendations preventive mitigating measures provided accordance marketing authorisation holders referred paragraph provide comments b take account recommendations referred guidelines referred point c c comply measures taken state level pursuant articles inform measures taken report monitoring results measures including providing resolution actual potential shortage medicinal products order facilitate monitoring referred unless concerned available esmp may request state submit set referred including available estimated volume demand demand forecasts single point contact referred using reporting methods systems established pursuant points b c respectively b indicate existence commercially confidential explain commercially confidential nature accordance c indicate failure provide requested whether delays providing deadline set accordance comply ’ request deadline set purposes paragraph wholesale distributors persons legal entities authorised entitled supply medicinal products included critical medicines lists public provide state relevant including levels stock medicinal products request state addition provided accordance paragraphs volumes sales volumes prescriptions medicinal products provides evidence actual potential shortage medicinal product included critical medicines lists including referred third paragraph immediately provide respective single points contact referred following reporting results monitoring referred recommendations preventive mitigating measures provided accordance take account recommendations guidelines referred point c coordinate actions relation actions taken level pursuant point b inform measures taken report results actions referred point including providing resolution actual potential shortage medicinal products purposes first subparagraph points b take alternative course action national level share reasons timely manner recommendations guidelines actions referred first subparagraph point summary report lessons learned made publicly available via web portal referred take account recommendations referred respectively take necessary action within limits powers conferred view mitigating actual potential shortages medicinal products included critical medicines lists b facilitate coordination marketing authorisation holders relevant entities address demand surges necessary c consider need guidelines recommendations addressed marketing authorisation holders entities including relevant entities supply chain medicinal products relevant inform measures taken report results measures e request provide recommendations coordinate measures provided f consider need medical countermeasures accordance decision applicable law g liaise third countries relevant international organisations appropriate mitigate actual potential shortages medicinal products included critical medicines lists active substances medicinal products active substances imported actual potential shortages international implications report related actions well results actions relevant set maintain manage platform known shortages monitoring platform ‘ esmp ’ linked database referred point l esmp used facilitate collection shortages supply demand medicinal products including whether medicinal product placed ceases placed market state collected esmp used monitor prevent manage actual potential shortages medicinal products critical medicines lists public health emergencies major events b actual potential shortages medicinal products likely lead public health emergency major event accordance purposes paragraph public health emergenciesand major events marketing authorisation holders use esmp report relating medicinal products critical medicines lists single points contact referred point accordance articles b use esmp report relating medicinal products critical medicines lists single points contact referred point accordance articles reporting referred first subparagraph point b include addition referred point received marketing authorisation holders wholesale distributors persons legal entities authorised entitled supply public medicinal products included critical medicines lists relevant purposes paragraph regards ensuring preparedness public health emergencies major events marketing authorisation holders use esmp report referred authorisations granted accordance ii based categories set relate actual potential shortages medicinal products likely lead public health emergency major event appropriate b use esmp report shortages medicinal products likely lead public health emergency major event accordance single points contact referred point e reporting referred paragraph point b include referred reported national competent authorities medicinal products authorisations granted accordance b may include additional received marketing authorisation holders wholesale distributors persons legal entities authorised entitled supply medicinal products public ensure optimal use esmp develop technical functional specifications esmp including exchange mechanism exchanging existing national systems format electronic submissions collaboration b require submitted esmp comply standards developed international organization standardization identification medicinal products based domains master pharmaceutical regulatory processes namely substance product organisation referential relevant c develop standardised reporting terminology used marketing authorisation holders reporting esmp collaboration establish relevant guidance reporting esmp collaboration e ensure interoperable esmp ’ systems relevant systems databases without duplication reporting f ensure national competent authorities appropriate levels access contained esmp g ensure commercially confidential submitted system protected unjustified disclosure h ensure esmp fully operational february draw plan implementation esmp provide public interest groups regard work timely manner respond disinformation targeting work appropriate via dedicated webpage web portal appropriate means cooperation national competent authorities proceedings transparent summaries agenda minutes meetings well rules procedure referred recommendations referred documented made publicly available dedicated webpage web portal rules procedure referred allow members divergent opinions recorded make divergent opinions grounds based available national competent authorities medicinal products request emergency task force ‘ ’ hereby established within convened preparation public health emergencies either person remotely provide secretariat public health emergencies undertake following tasks liaison scientific committees working parties scientific advisory groups providing scientific advice reviewing available scientific medicinal products potential address public health emergency including requesting developers engaging preliminary discussions b providing advice main aspects clinical trial protocols providing advice developers clinical trials medicinal products intended treat prevent diagnose disease causing public health emergency accordance without prejudice tasks regards assessment submitted clinical trial applications conducted within territories accordance c providing scientific support facilitate clinical trials medicinal products intended treat prevent diagnose disease causing public health emergency contributing work scientific committees working parties scientific advisory groups e liaison scientific committees working parties scientific advisory groups providing scientific recommendations regard use medicinal product potential address public health emergencies accordance f cooperating national competent authorities bodies agencies world health organization third countries international scientific organisations scientific technical issues relate public health emergency medicinal products potential address public health emergencies necessary support referred first subparagraph point c include advice sponsors similar linked planned clinical trials establishment joint clinical trials may include advice establishing agreements act sponsor cosponsor accordance point members consist chairs vice chairs scientific committees representatives committees b representatives working parties including representatives pcwp representatives hcpwp c staff members representatives coordination group established accordance e representatives clinical trials coordination advisory group established accordance f clinical trial experts represent national competent authorities medicinal products members nominated entities represent external experts may appointed ad hoc basis necessary especially cases referred representatives bodies agencies invited ad hoc basis necessary participate work especially cases referred chaired representative cochaired chair vicechair chmp composition approved management board taking account specific expertise relevant therapeutic response public health emergency executive director representative executive director well representatives management board entitled attend meetings composition made publicly available cochairs may invite representatives members scientific committees working parties third parties including representatives medicinal product interest groups marketing authorisation holders developers clinical trial sponsors representatives clinical trial networks independent clinical trial experts researchers representatives healthcare professionals patients attend meetings establish rules procedure including rules adoption recommendations rules procedure referred first subparagraph enter force received favourable opinion management board perform tasks advisory support body separate without prejudice tasks scientific committees regards authorisation supervision pharmacovigilance medicinal products concerned related regulatory actions ensure quality safety efficacy medicinal products chmp relevant scientific committees take recommendations consideration adopting opinions take account scientific opinion issued committees referred second subparagraph paragraph accordance applies regards transparency independence members publish regarding medicinal products considers potential address public health emergencies updates web portal inform hsc appropriate publication without undue delay case prior publication public health emergency provide advice main aspects clinical trials clinical trial protocols submitted intended submitted clinical trial application developers part accelerated scientific advice process without prejudice responsibility state concerned developer engages accelerated scientific advice process provide advice referred paragraph free charge latest days developer submits complete set requested advice endorsed chmp establish procedures guidance requesting submitting set required including state application authorisation clinical trial submitted intended submitted involve representatives clinical trial expertise preparation scientific advice particular cases application authorisation clinical trial submitted intended submitted authorising clinical trial application provided scientific advice take advice consideration scientific advice provided without prejudice ethical review provided developer recipient scientific advice referred paragraph developer subsequently submit resulting clinical trials makes request pursuant without prejudice paragraphs scientific advice referred paragraph otherwise provided accordance procedures established pursuant duration public health emergency sponsors clinical trials conducted particular make following publicly available portal database established respectively articles clinical trial protocol start trial trials authorised examine medicinal products potential address public health emergency b summary results within timeline set shorter timeline laid medicinal product relevance public health emergency receives marketing authorisation publish particular product details conditions use time marketing authorisation b public assessment reports soon possible possible within seven days marketing authorisation c clinical submitted support application possible within two months marketing authorisation entire risk management plan referred point c updated versions thereof purposes first subparagraph point c anonymise personal redact commercially confidential following recognition public health emergency undertake review available scientific medicinal products potential used address public health emergency review updated whenever needed public health emergency including chmp agree preparation assessment marketing authorisation application preparation review referred paragraph may request marketing authorisation holders developers may engage preliminary discussions may also make use health generated outside clinical studies available taking account reliability may liaise third country agencies medicinal products respect additional exchanges following request one provide recommendations chmp opinion accordance paragraph compassionate use medicinal products falling scope b use distribution unauthorised medicinal product accordance following receipt recommendation provided pursuant paragraph chmp adopt opinion conditions imposed use distribution medicinal product concerned patients targeted opinion updated necessary take account opinions referred paragraph applies use opinion preparation recommendations provided pursuant paragraphs may consult state concerned request provide available state used decision make medicinal product available compassionate use following request state provide requested provide public relevant interest groups regard work timely manner respond disinformation targeting work appropriate via dedicated webpage web portal appropriate means cooperation national competent authorities regularly publish web portal list members rules procedure referred list medicinal products review well opinions adopted pursuant preparation support work public health emergencies develop maintain tools including interoperable platform submission including electronic health generated outside clinical studies facilitate interoperability existing tools tools development provide adequate support national competent authorities b coordinate independent monitoring studies use effectiveness safety medicinal products intended treat prevent diagnose diseases related public health emergency using relevant including relevant held public authorities c part regulatory tasks make use digital infrastructures tools order facilitate rapid access analysis available electronic health generated outside clinical studies facilitate exchange bodies provide access external sources electronic health access including health generated outside clinical studies purposes first paragraph point b coordination regards vaccines conducted conjunction ecdc particular new vaccine monitoring platform executive steering group shortages medical devices ‘ medical device shortages steering group – ’ hereby established within responsible fulfilling tasks referred articles meet regularly also whenever situation requires either person remotely preparation public health emergency provide secretariat members consist representative representative one representative appointed state representatives expertise field medical devices relevant representatives may representatives appointed medical devices coordination group established ‘ mdcg ’ appropriate members may accompanied meetings experts specific scientific technical fields list members published ’ web portal representative pcwp representative hcpwp may attend meetings observers cochaired representative one representatives elected among representatives cochairs initiative request one members may invite observers provide expert advice third parties including representatives medical device interest groups representatives manufacturers notified bodies relevant actor supply chain medical devices representatives healthcare professionals patients consumers attend meetings necessary establish rules procedure including procedures relating working party referred paragraph procedures adoption lists referred sets recommendations referred rules procedure referred first subparagraph enter force received favourable opinion management board supported work working party established accordance working party referred first subparagraph consist representatives national competent authorities responsible shortage monitoring management medical devices single points contact relation shortages medical devices immediately following recognition public health emergency consult working party referred immediately following consultation adopt list categories critical medical devices considers critical public health emergency ‘ public health emergency critical devices list ’ extent possible relevant critical medical devices related manufacturers gathered eudamed fully functional also gathered importers distributors appropriate eudamed fully functional available may also gathered national databases available sources update public health emergency critical devices list whenever necessary termination recognition public health emergency purposes adopt make publicly available set referred points b c necessary monitor supply demand medical devices included public health emergency critical devices list inform working party referred set publish dedicated webpage web portal public health emergency critical devices list well updates list b actual shortages critical medical devices included public health emergency critical devices list public health emergency monitor supply demand medical devices included public health emergency critical devices list view identifying actual potential shortages medical devices conduct monitoring using public health emergency critical devices list provided accordance articles purposes monitoring referred first subparagraph paragraph relevant liaise mdcg hsc relevant advisory committee public health emergencies established pursuant law purposes monitoring referred paragraph may make use device registries databases available may take account generated pursuant duration public health emergency regularly report results monitoring referred single points contact referred point particular signal actual potential shortages medical devices included public health emergency critical devices list requested one single point contact referred point provide aggregated demand forecasts support findings conclusions purposes first subparagraph liaise ecdc obtain epidemiological help forecast medical device needs medical devices included public health emergency critical devices list used jointly medicinal product findings conclusions referred first subparagraph may made available actors medical device sector appropriate accordance competition law view well preventing mitigating actual potential shortages part reporting referred paragraphs may provide recommendations measures medical device manufacturers notified bodies entities could take prevent mitigate actual potential shortages medical devices purposes first subparagraph liaise relevant mdcg hsc relevant advisory committee public health emergencies established pursuant law initiative request may provide recommendations measures manufacturers medical devices notified bodies entities could take ensure preparedness dealing actual potential shortages medical devices caused public health emergencies requested may coordinate measures taken national competent authorities medical devices manufacturers medical devices notified bodies entities relevant prevent mitigate actual potential shortages medical devices context public health emergency major event order prepare fulfilment tasks referred articles specify procedures criteria establishing reviewing public health emergency critical devices list b develop streamlined monitoring reporting systems coordination relevant national competent authorities facilitate interoperability existing tools eudamed fully functional provide adequate support national competent authorities monitoring reporting c establish working party referred ensure state represented working party specify methods provision recommendations referred coordination measures referred purposes first subparagraph point mdcg representatives manufacturers relevant actors supply chain medical device sector representatives healthcare professionals patients consumers may consulted necessary following recognition public health emergency establish list single points contact manufacturers medical devices authorised representatives importers notified bodies medical devices included public health emergency critical devices list b maintain list single points contact referred point duration public health emergency c request relevant medical devices included public health emergency critical devices list single points contact referred point basis set adopted set deadline submission request relevant medical devices included public health emergency critical devices list single points contact referred second subparagraph basis set adopted accordance set deadline submission may use sources referred first subparagraph including existing databases databases development gather required paragraph purposes first subparagraph point considered relevant national databases including eudamed fully functional medical device associations may used sources referred paragraph point c include least name manufacturer medical device applicable name authorised representative b identifying medical device intended purpose necessary specific characteristics medical device c applicable name number notified body regarding relevant certificate certificates details actual potential shortage medical device actual estimated start end dates suspected known cause e sales market share medical device f available stocks medical device g forecast supply medical device including potential vulnerabilities supply chain h quantities already delivered projected deliveries medical device demand forecasts medical device j shortage prevention mitigation plans include minimum production supply capacity k relevant notified bodies regarding capacity process applications carry complete conformity assessments relation medical devices included public health emergency critical devices list within appropriate period time considering emergency l number applications received relevant notified bodies relation medical devices included public health emergency critical devices list relevant conformity assessment procedures conformity assessments ongoing status conformity assessment relevant notified bodies relation medical devices included public health emergency critical devices list possible critical issues final outcome assessment need considered order complete conformity assessment process purposes first subparagraph point k relevant notified bodies communicate date assessment expected completed regard notified bodies prioritise conformity assessments medical devices included public health emergency critical devices list order facilitate monitoring referred may request manufacturers medical devices authorised representatives applicable appropriate importers distributors included public health emergency critical devices list necessary relevant notified bodies submit requested deadline set manufacturers medical devices authorised representatives applicable appropriate importers distributors referred first subparagraph submit requested single points contact referred point using monitoring reporting systems established pursuant point b provide updates necessary manufacturers medical devices authorised representatives applicable notified bodies appropriate importers distributors justify failure provide requested delays providing requested deadline set manufacturers medical devices authorised representatives notified bodies appropriate importers distributors indicate submitted contains commercially confidential nature identify relevant parts nature explain commercially confidential nature assess merits indication commercially confidential nature protect commercially confidential unjustified disclosure manufacturers medical devices authorised representatives notified bodies appropriate importers distributors addition required paragraph provides evidence actual potential shortage medical devices immediately provide following reporting results monitoring referred recommendations preventive mitigating measures provided accordance manufacturers medical devices authorised representatives appropriate importers distributors referred paragraph provide comments b take account recommendations referred guidelines referred point b c comply measures taken state level pursuant inform measures taken report results measures including providing resolution actual potential shortage medical devices manufacturers medical devices referred paragraph established outside requested accordance provided authorised representatives appropriate importers distributors order facilitate monitoring referred may request state submit set referred including available needs related medical devices included public health emergency critical devices list available estimated volume demand demand forecasts medical devices respective single point contact referred point using monitoring reporting methods systems established pursuant point b b indicate existence commercially confidential explain commercially confidential nature accordance c indicate failure provide requested whether delays providing deadline set accordance comply ’ request deadline set purposes paragraph gather manufacturers medical devices authorised representatives healthcare providers importers distributors applicable notified bodies medical devices included public health emergency critical devices list addition provided accordance paragraphs provides evidence actual potential shortage medical devices immediately provide respective single point contact referred point following reporting results monitoring referred recommendations preventive mitigating measures provided accordance consider need provide temporary exemptions state level pursuant view mitigating actual potential shortages medical devices included public health emergency critical devices list ensuring high level patient product safety b take account recommendations referred guidelines referred point b coordinate actions relation actions taken level pursuant point c inform measures taken report results actions referred point b including providing resolution actual potential shortage medical devices concerned purposes first subparagraph points b c take alternative course action national level share reasons recommendations guidelines actions referred first subparagraph point b paragraph summary report lessons learned made publicly available via web portal referred take account recommendations take necessary action within limits powers conferred view mitigating actual potential shortages medical devices included public health emergency critical devices list including necessary granting temporary exemptions level pursuant respecting conditions set articles seeking ensure patient product safety b consider need guidelines recommendations addressed manufacturers medical devices notified bodies entities relevant c request provide recommendations coordinate measures provided consider need medical countermeasures accordance decision applicable law e liaise third countries relevant international organisations appropriate mitigate actual potential shortages medical devices included public health emergency critical devices list component parts devices parts devices imported actual potential shortages international implications report related actions well results actions relevant provide public relevant interest groups regard work timely manner respond disinformation targeting work appropriate via dedicated webpage web portal appropriate means cooperation national competent authorities proceedings transparent summaries agenda minutes meetings well rules procedure referred recommendations referred documented made publicly available dedicated webpage web portal rules procedure referred allow members divergent opinions recorded make divergent opinions grounds based available national competent authorities request march behalf provide secretariat expert panels designated accordance ‘ expert panels ’ provide support necessary ensure expert panels efficiently perform tasks set provide administrative technical support expert panels provision scientific opinions views advice b facilitate manage remote physical meetings expert panels c ensure work expert panels carried independent manner accordance second subparagraph systems procedures established pursuant actively manage prevent potential conflicts interest accordance third subparagraph maintain regularly update webpage expert panels make necessary already publicly available eudamed publicly available webpage order ensure transparency activities expert panels including providing justifications notified bodies bodies follow advice expert panels provided pursuant e publish scientific opinions views advice expert panels ensuring confidentiality accordance second subparagraph f ensure remuneration expenses provided experts accordance implementing acts adopted pursuant g monitor compliance expert panels ’ common rules procedure available guidelines methodologies relevant functioning expert panels h provide annual reports mdcg work expert panels including number opinions delivered views advice provided expert panels ensure cooperate relation measures address public health emergencies major events members members working parties referred point respectively may attend one another ’ meetings working parties appropriate cooperate monitoring exercises reporting preparation opinions agreement respective chairs cochairs joint meetings may held relevant ensure expert panels cooperate relation preparedness management public health emergencies carry activities independent impartial transparent manner members relevant observers financial interests medicinal products industry medical devices industry could affect independence impartiality members relevant observers make declaration financial interests update declarations interest annually whenever necessary declarations referred first subparagraph made publicly available ’ web portal members relevant observers disclose facts become aware might reasonably expected good faith involve give rise conflict interest meeting members relevant observers participate meetings declare interests could considered prejudicial independence impartiality respect items agenda decides interest declared accordance paragraph constitutes conflict interest observer concerned take part discussions decision making obtain concerning item concern agenda declarations decisions referred paragraphs respectively recorded summary minutes meeting members relevant observers subject requirement professional secrecy even duties ceased members update annual declaration financial interests provided whenever relevant change declaration occurs equip high level security controls processes cyber attacks cyber espionage breaches ensure protection health normal functioning times especially public health emergencies major events level purposes first paragraph actively identify implement cybersecurity best practices adopted within institutions bodies offices agencies preventing detecting mitigating responding cyber attacks unless otherwise provided without prejudice parliament parliament existing national provisions practices confidentiality parties involved application respect confidentiality obtained carrying tasks order protect commercially confidential trade secrets natural legal persons accordance parliament including intellectual property rights without prejudice paragraph parties involved application ensure commercially confidential shared way potential enable undertakings restrict distort competition within meaning tfeu without prejudice paragraph exchanged confidential basis national competent authorities national competent authorities disclosed without prior agreement authority originates paragraphs affect rights obligations actors identified regard exchange dissemination warnings affect obligations persons concerned provide criminal law may exchange commercially confidential regulatory authorities third countries concluded bilateral multilateral confidentiality arrangements transfers personal subject regulations applicable regards transfers personal third country absence adequacy decision appropriate safeguards referred respectively may carry certain transfers personal regulatory authorities third countries put place confidentiality arrangements transfers necessary important reasons public interest protection public health transfers made conformity conditions laid december every fourth year thereafter present report parliament application particular report review crisis preparedness management framework medicinal products medical devices including outcomes periodic stress tests b instances noncompliance obligations set articles marketing authorisation holders manufacturers medical devices authorised representatives importers distributors notified bodies c remit functioning esmp notwithstanding paragraph following public health emergency major event present timely manner report parliament instances referred paragraph point b based report referred paragraph appropriate present legislative proposal order amend particular consider need extending scope veterinary medicinal products personal protective equipment medical use b amending c introducing measures strengthen national level compliance obligations established articles expanding remit esmp need facilitating esmp interoperability national systems need national shortage monitoring platforms need meeting additional requirements address structural shortages medicinal products may introduced context revision provide financing ’ activities support work working parties referred point c expert panels involve cooperation ecdc ’ financial assistance activities implemented accordance euratom parliament remunerate assessment activities rapporteurs relation addition reimbursing expenses incurred ’ representatives experts relation meetings working parties referred accordance financial arrangements established management board remuneration paid relevant national competent authorities contribution provided cover tasks provided cover full amount remuneration paid national competent authorities medicinal products fee exemptions apply accordance enter force day following publication apply march however exception chapter iv apply february binding entirety directly applicable done brussels january'"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Checking outcome of Preprocessing\n",
    "clean_txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "99a7ace9",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Vectorizing data\n",
    "\n",
    "# vectorizer = CountVectorizer()\n",
    "# vectorized_text = vectorizer.fit_transform(clean_txt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "0dd3053b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# bigram vectorization\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "vectorizer_n_gram = TfidfVectorizer(ngram_range = (1,1)) # BI-GRAMS\n",
    "cleaned_vectorizer_n_gram = vectorizer_n_gram.fit_transform([clean_txt])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "7f44aed9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ability</th>\n",
       "      <th>able</th>\n",
       "      <th>absence</th>\n",
       "      <th>academia</th>\n",
       "      <th>accelerated</th>\n",
       "      <th>accelerating</th>\n",
       "      <th>access</th>\n",
       "      <th>accessed</th>\n",
       "      <th>accessible</th>\n",
       "      <th>accessories</th>\n",
       "      <th>...</th>\n",
       "      <th>without</th>\n",
       "      <th>work</th>\n",
       "      <th>working</th>\n",
       "      <th>world</th>\n",
       "      <th>worsening</th>\n",
       "      <th>would</th>\n",
       "      <th>year</th>\n",
       "      <th>years</th>\n",
       "      <th>zoonoses</th>\n",
       "      <th>zoonotic</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.003103</td>\n",
       "      <td>0.012412</td>\n",
       "      <td>0.003103</td>\n",
       "      <td>0.003103</td>\n",
       "      <td>0.003103</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.012412</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.003103</td>\n",
       "      <td>...</td>\n",
       "      <td>0.026375</td>\n",
       "      <td>0.034132</td>\n",
       "      <td>0.046544</td>\n",
       "      <td>0.004654</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.012412</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.001551</td>\n",
       "      <td>0.004654</td>\n",
       "      <td>0.001551</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1 rows × 1517 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    ability      able   absence  academia  accelerated  accelerating  \\\n",
       "0  0.003103  0.012412  0.003103  0.003103     0.003103      0.001551   \n",
       "\n",
       "     access  accessed  accessible  accessories  ...   without      work  \\\n",
       "0  0.012412  0.001551    0.001551     0.003103  ...  0.026375  0.034132   \n",
       "\n",
       "    working     world  worsening     would      year     years  zoonoses  \\\n",
       "0  0.046544  0.004654   0.001551  0.012412  0.001551  0.001551  0.004654   \n",
       "\n",
       "   zoonotic  \n",
       "0  0.001551  \n",
       "\n",
       "[1 rows x 1517 columns]"
      ]
     },
     "execution_count": 110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "\n",
    "df = pd.DataFrame(cleaned_vectorizer_n_gram.toarray(), columns=vectorizer_n_gram.get_feature_names_out())\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "id": "3d7853fb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ability        0.003103\n",
       "able           0.012412\n",
       "absence        0.003103\n",
       "academia       0.003103\n",
       "accelerated    0.003103\n",
       "                 ...   \n",
       "would          0.012412\n",
       "year           0.001551\n",
       "years          0.001551\n",
       "zoonoses       0.004654\n",
       "zoonotic       0.001551\n",
       "Name: 0, Length: 1517, dtype: float64"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.T[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "id": "9e31fd7a",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Modelling\n",
    "\n",
    "# Instantiating the LDA \n",
    "n_components = 3\n",
    "lda_model = LatentDirichletAllocation(n_components=n_components, max_iter = 100)\n",
    "\n",
    "# Fitting the LDA on the vectorized documents\n",
    "lda_model.fit(cleaned_vectorizer_n_gram)\n",
    "\n",
    "# Getting topics\n",
    "topics = lda_model.transform(cleaned_vectorizer_n_gram)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "f702cef9",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Topic model function from ML-10-lecture\n",
    "def print_topics(model, vectorizer_n_gram, top_words):\n",
    "    for idx, topic in enumerate(model.components_):\n",
    "        print(\"-\"*20)\n",
    "        print(\"Topic %d:\" % (idx))\n",
    "        print([(vectorizer_n_gram.get_feature_names_out()[i], round(topic[i],2))\n",
    "                        for i in topic.argsort()[:-top_words - 1:-1]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "bc0aea23",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--------------------\n",
      "Topic 0:\n"
     ]
    },
    {
     "ename": "NotFittedError",
     "evalue": "Vocabulary not fitted or provided",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNotFittedError\u001b[0m                            Traceback (most recent call last)",
      "Input \u001b[0;32mIn [108]\u001b[0m, in \u001b[0;36m<cell line: 3>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;66;03m#Printing topics\u001b[39;00m\n\u001b[0;32m----> 3\u001b[0m \u001b[43mprint_topics\u001b[49m\u001b[43m(\u001b[49m\u001b[43mlda_model\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mvectorizer_n_gram\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtop_words\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;241;43m8\u001b[39;49m\u001b[43m)\u001b[49m\n",
      "Input \u001b[0;32mIn [107]\u001b[0m, in \u001b[0;36mprint_topics\u001b[0;34m(model, vectorizer_n_gram, top_words)\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m-\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m20\u001b[39m)\n\u001b[1;32m      5\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mTopic \u001b[39m\u001b[38;5;132;01m%d\u001b[39;00m\u001b[38;5;124m:\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m%\u001b[39m (idx))\n\u001b[0;32m----> 6\u001b[0m \u001b[38;5;28mprint\u001b[39m([(vectorizer_n_gram\u001b[38;5;241m.\u001b[39mget_feature_names_out()[i], \u001b[38;5;28mround\u001b[39m(topic[i],\u001b[38;5;241m2\u001b[39m))\n\u001b[1;32m      7\u001b[0m                 \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m topic\u001b[38;5;241m.\u001b[39margsort()[:\u001b[38;5;241m-\u001b[39mtop_words \u001b[38;5;241m-\u001b[39m \u001b[38;5;241m1\u001b[39m:\u001b[38;5;241m-\u001b[39m\u001b[38;5;241m1\u001b[39m]])\n",
      "Input \u001b[0;32mIn [107]\u001b[0m, in \u001b[0;36m<listcomp>\u001b[0;34m(.0)\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m-\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m20\u001b[39m)\n\u001b[1;32m      5\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mTopic \u001b[39m\u001b[38;5;132;01m%d\u001b[39;00m\u001b[38;5;124m:\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m%\u001b[39m (idx))\n\u001b[0;32m----> 6\u001b[0m \u001b[38;5;28mprint\u001b[39m([(\u001b[43mvectorizer_n_gram\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mget_feature_names_out\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m[i], \u001b[38;5;28mround\u001b[39m(topic[i],\u001b[38;5;241m2\u001b[39m))\n\u001b[1;32m      7\u001b[0m                 \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m topic\u001b[38;5;241m.\u001b[39margsort()[:\u001b[38;5;241m-\u001b[39mtop_words \u001b[38;5;241m-\u001b[39m \u001b[38;5;241m1\u001b[39m:\u001b[38;5;241m-\u001b[39m\u001b[38;5;241m1\u001b[39m]])\n",
      "File \u001b[0;32m~/.pyenv/versions/3.8.12/envs/BatchLegal/lib/python3.8/site-packages/sklearn/feature_extraction/text.py:1454\u001b[0m, in \u001b[0;36mCountVectorizer.get_feature_names_out\u001b[0;34m(self, input_features)\u001b[0m\n\u001b[1;32m   1441\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mget_feature_names_out\u001b[39m(\u001b[38;5;28mself\u001b[39m, input_features\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m):\n\u001b[1;32m   1442\u001b[0m     \u001b[38;5;124;03m\"\"\"Get output feature names for transformation.\u001b[39;00m\n\u001b[1;32m   1443\u001b[0m \n\u001b[1;32m   1444\u001b[0m \u001b[38;5;124;03m    Parameters\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1452\u001b[0m \u001b[38;5;124;03m        Transformed feature names.\u001b[39;00m\n\u001b[1;32m   1453\u001b[0m \u001b[38;5;124;03m    \"\"\"\u001b[39;00m\n\u001b[0;32m-> 1454\u001b[0m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_check_vocabulary\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1455\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m np\u001b[38;5;241m.\u001b[39masarray(\n\u001b[1;32m   1456\u001b[0m         [t \u001b[38;5;28;01mfor\u001b[39;00m t, i \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28msorted\u001b[39m(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mvocabulary_\u001b[38;5;241m.\u001b[39mitems(), key\u001b[38;5;241m=\u001b[39mitemgetter(\u001b[38;5;241m1\u001b[39m))],\n\u001b[1;32m   1457\u001b[0m         dtype\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mobject\u001b[39m,\n\u001b[1;32m   1458\u001b[0m     )\n",
      "File \u001b[0;32m~/.pyenv/versions/3.8.12/envs/BatchLegal/lib/python3.8/site-packages/sklearn/feature_extraction/text.py:506\u001b[0m, in \u001b[0;36m_VectorizerMixin._check_vocabulary\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    504\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_validate_vocabulary()\n\u001b[1;32m    505\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mfixed_vocabulary_:\n\u001b[0;32m--> 506\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m NotFittedError(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mVocabulary not fitted or provided\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m    508\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mvocabulary_) \u001b[38;5;241m==\u001b[39m \u001b[38;5;241m0\u001b[39m:\n\u001b[1;32m    509\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mVocabulary is empty\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "\u001b[0;31mNotFittedError\u001b[0m: Vocabulary not fitted or provided"
     ]
    }
   ],
   "source": [
    "#Printing topics\n",
    "\n",
    "print_topics(lda_model, vectorizer_n_gram, top_words = 8)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e85f0f5b",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.12"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
